Skip to content
Daily Royal Base

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Deal Because of Data Concerns

Health funding illustration
The proposed US financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive information.

This move was revealed after a official document from December was disclosed, indicating that President Emmerson Mnangagwa felt the agreement was "skewed".

An official spokesman later clarified that the United States was seeking health data for scientific study and commercial gain while was not willing to guarantee the resulting advantages from future medical innovations.

"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for more negotiations to reach a agreement acceptable to all parties so the country's critical HIV programme can proceed.

Broader Background

This rejection follows a similar case in Kenya, where a court suspended a related health funding agreement following concerns were raised about the safety of Kenyans' health data.

After returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and accountability.

As per reports, 16 African countries have so far signed similar health pacts, representing more than $18.3bn in committed funds.

Specifics of the Rejected Agreement

The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership could have provided significant advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," the Ambassador commented.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Effectively, our nation would provide the raw materials for medical research without any certainty that the end products would be accessible to our people if a future health crisis arise."

Sovereignty and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems previously set up via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.

"This framework is designed to guarantee that when a country contributes its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to create them."

The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We are open to further discussions with our American counterparts on how subsequent collaboration could be designed in a way that honours the sovereignty and dignity of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that talks need to persist given that a large portion of the country's HIV programmes relied on external financing.

"Where specific concerns arise, including those relating to data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group commented.

This impasse emphasises the ongoing challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

SN
Written by

Sandra Nelson

Eleanor is a royal historian and journalist with over a decade of experience covering European monarchies.

Daily Royal Base

Type to search articles.